Pacific Biosciences of California, Inc. Other Revenue, Net (Deprecated 2018-01-31)
Pacific Biosciences of California, Inc. (PACB) reported Other Revenue, Net (Deprecated 2018-01-31) of $13.44 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-26.
Discontinued › Income Statement › Other Income
us-gaap:OtherSalesRevenueNet · last filed 2018-02-26
- Pacific Biosciences of California, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $3.09M, a 18.32% decline year-over-year.
- Pacific Biosciences of California, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $3.20M, a 7.78% decline year-over-year.
- Pacific Biosciences of California, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $3.52M, a 1.09% decline year-over-year.
- Pacific Biosciences of California, Inc. other revenue, net (deprecated 2018-01-31) for the quarter ending 2017-03-31 was $3.62M, a 14.88% increase year-over-year.
- Pacific Biosciences of California, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2017 was $13.44M, a 3.82% decline from fiscal 2016.
- Pacific Biosciences of California, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2016 was $13.97M, a 28.22% increase from fiscal 2015.
- Pacific Biosciences of California, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2015 was $10.90M, a 28.02% increase from fiscal 2014.
- Pacific Biosciences of California, Inc. other revenue, net (deprecated 2018-01-31) for fiscal 2014 was $8.51M, a 32.04% increase from fiscal 2013.
| Period end | Other Revenue, Net (Deprecated 2018-01-31) 3 month | Other Revenue, Net (Deprecated 2018-01-31) 6 month | Other Revenue, Net (Deprecated 2018-01-31) 6 month as first filed | Other Revenue, Net (Deprecated 2018-01-31) 9 month | Other Revenue, Net (Deprecated 2018-01-31) 9 month as first filed | Other Revenue, Net (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|---|---|
| 2017-12-31 | $3.09M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $6.29M derived: sum of 2 quarters · filed 2018-02-26 | $9.82M derived: sum of 3 quarters · filed 2018-02-26 | $13.44M 10-K · filed 2018-02-26 | ||
| 2017-09-30 | $3.20M 10-Q · filed 2017-11-02 | $6.73M derived: sum of 2 quarters · filed 2017-11-02 | $10.35M 10-Q · filed 2017-11-02 | $14.13M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2017-06-30 | $3.52M 10-Q · filed 2017-08-02 | $7.15M 10-Q · filed 2017-08-02 | $10.93M derived: sum of 3 quarters · filed 2018-02-26 | $14.40M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2017-03-31 | $3.62M 10-Q · filed 2017-05-05 | $7.40M derived: sum of 2 quarters · filed 2018-02-26 | $10.88M derived: sum of 3 quarters · filed 2018-02-26 | $14.44M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-12-31 | $3.78M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $7.25M derived: sum of 2 quarters · filed 2018-02-26 | $10.82M derived: sum of 3 quarters · filed 2018-02-26 | $13.97M 10-K · filed 2018-02-26 | ||
| 2016-09-30 | $3.47M 10-Q · filed 2017-11-02 | $7.04M derived: sum of 2 quarters · filed 2017-11-02 | $10.19M 10-Q · filed 2017-11-02 | $13.07M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-06-30 | $3.56M 10-Q · filed 2017-08-02 | $6.72M 10-Q · filed 2017-08-02 | $9.60M derived: sum of 3 quarters · filed 2018-02-26 | $12.35M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2016-03-31 | $3.15M 10-Q · filed 2017-05-05 | $6.04M derived: sum of 2 quarters · filed 2018-02-26 | $8.79M derived: sum of 3 quarters · filed 2018-02-26 | $11.31M derived: sum of 4 quarters · filed 2018-02-26 | ||
| 2015-12-31 | $2.89M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $5.64M derived: sum of 2 quarters · filed 2018-02-26 | $8.15M derived: sum of 3 quarters · filed 2018-02-26 | $10.90M 10-K · filed 2018-02-26 | ||
| 2015-09-30 | $2.75M 10-Q · filed 2016-11-04 | $5.27M derived: sum of 2 quarters · filed 2016-11-04 | $8.01M 10-Q · filed 2016-11-04 | $10.29M derived: sum of 4 quarters · filed 2017-03-06 | ||
| 2015-06-30 | $2.52M 10-Q · filed 2016-08-04 | $5.26M 10-Q · filed 2016-08-04 | $7.54M derived: sum of 3 quarters · filed 2017-03-06 | $9.71M derived: sum of 4 quarters · filed 2017-03-06 | ||
| 2015-03-31 | $2.74M 10-Q · filed 2016-05-05 | $5.03M derived: sum of 2 quarters · filed 2017-03-06 | $7.19M derived: sum of 3 quarters · filed 2017-03-06 | $9.17M derived: sum of 4 quarters · filed 2017-03-06 | ||
| 2014-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-06 | $4.45M derived: sum of 2 quarters · filed 2017-03-06 | $6.43M derived: sum of 3 quarters · filed 2017-03-06 | $8.51M 10-K · filed 2017-03-06 | ||
| 2014-09-30 | $2.17M 10-Q · filed 2015-11-05 | $4.14M derived: sum of 2 quarters · filed 2015-11-05 | $6.23M 10-Q · filed 2015-11-05 | $7.87M derived: sum of 4 quarters · filed 2016-03-11 | ||
| 2014-06-30 | $1.98M 10-Q · filed 2015-08-05 | $4.06M 10-Q · filed 2015-08-05 | $5.71M derived: sum of 3 quarters · filed 2016-03-11 | $7.31M derived: sum of 4 quarters · filed 2016-03-11 | ||
| 2014-03-31 | $2.08M 10-Q · filed 2015-05-05 | $3.73M derived: sum of 2 quarters · filed 2016-03-11 | $5.33M derived: sum of 3 quarters · filed 2016-03-11 | $6.78M derived: sum of 4 quarters · filed 2016-03-11 | ||
| 2013-12-31 | $1.65M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | $3.25M derived: sum of 2 quarters · filed 2016-03-11 | $4.70M derived: sum of 3 quarters · filed 2016-03-11 | $6.45M 10-K · filed 2016-03-11 | ||
| 2013-09-30 | $1.61M 10-Q · filed 2014-11-05 | $3.05M derived: sum of 2 quarters · filed 2014-11-05 | $4.80M 10-Q · filed 2014-11-05 | $4.53M 10-Q · filed 2013-11-12 | $7.07M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-06-30 | $1.45M 10-Q · filed 2014-08-05 | $3.19M 10-Q · filed 2014-08-05 | $2.92M 10-Q · filed 2013-08-09 | $5.47M derived: sum of 3 quarters · filed 2015-03-12 | $6.75M derived: sum of 4 quarters · filed 2015-03-12 | |
| 2013-03-31 | $1.75M 10-Q · filed 2014-05-08 | $4.02M derived: sum of 2 quarters · filed 2015-03-12 | $5.30M derived: sum of 3 quarters · filed 2015-03-12 | $6.59M derived: sum of 4 quarters · filed 2015-03-12 | ||
| 2012-12-31 | $2.27M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-12 | $3.56M derived: sum of 2 quarters · filed 2015-03-12 | $4.84M derived: sum of 3 quarters · filed 2015-03-12 | $5.89M 10-K · filed 2015-03-12 | ||
| 2012-09-30 | $1.28M 10-Q · filed 2013-11-12 | $2.57M derived: sum of 2 quarters · filed 2013-11-12 | $3.62M 10-Q · filed 2013-11-12 | |||
| 2012-06-30 | $1.28M 10-Q · filed 2013-08-09 | $2.34M 10-Q · filed 2013-08-09 | ||||
| 2011-12-31 | $2.38M 10-K · filed 2014-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| ASTROTECH Corp (ASTC) | United States | $0.013B |